One of the founders of Bitfarms sold 1 million shares of the Brossard bitcoin miner earlier this week.
Emiliano Grodzki did his thing on Monday. He is the CEO and member of the board of directors of the company Bitfarms. He still has 6.6 million shares left in his account. The company’s stock has been in decline since it peaked at $10 last year. The stock closed the week at 86 cents in Toronto. Founded in 2017, Bitfarms jumped onto the stock market in 2019. The stock has basically returned to its original price from three years ago.
Title NanoXplore Declining sharply since financial results were disclosed in mid-November, the drop in shares of the Montreal graphene producer reflects the typical behavior of a small, hasty retail investor looking to make a quick profit, according to portfolio managers Charles Marlowe and Bill Mitchell of Gestion Palos.
“For impatient long-term investors like ourselves, the comments the executives made during our recent discussions with them confirm that the company’s growth potential remains significant and the strategic plan for the next five years is solid. We have taken advantage of the downturn to buy more shares,” they noted in their financial letter. weekly.
responsible in WSP It just bought nearly $100,000 worth of stock in a Montreal Engineering Services company. Birgit Norgaard bought a block of 600 shares on 17 November. I paid the unit price of $159.47. She has been a member of the WSP Board of Directors since 2013.
Opsens It remains unanimous on Bay Street, but one analyst revised its recommendation on Tuesday after the Quebec medical device specialist reported its year-end performance. Rahul Sarogaser of Raymond James still suggests buying the stock, but with more restraint. His proposal simply changes to “buy”, whereas previously it was a Solid deal. This expert continues to demonstrate strong confidence in the commercial potential of Opsens’ new guidewire for catheter-based aortic valve replacement procedures. He believes, however, that the stock will be volatile in the short term given the macroeconomic context pressuring valuation multiples in the medical technology sector.
With the death of bitcoin beginning to be announced again by some in the media, it is important to remember that this is not the first crisis in the industry. Each time, bitcoin rose stronger,” comments Martin Lalonde, portfolio manager at Rivemont, a company that privately manages a cryptocurrency fund.
“Nobody doubts at this point that 2022 is going to be a disastrous year for the mother of cryptocurrencies. However, when you look at the data, when in the past did it make sense to invest in an asset? And as we said earlier, that evidence only stands in retrospect.” adds in his weekly financial message.
chairman stingray He just bought nearly $615,000 in stock in a Montreal-based music service provider. Marc Pathé bought a block of 125,000 shares on November 16 at a unit price of $4.90.
Canadian securities managers saw fit earlier this week to warn investors against trading crypto assets, which “involve a high level of risk that may not be suitable for many of them,” especially retail investors. “In general, the value and liquidity of crypto assets is very volatile,” she says.
“Unlisted crypto-asset trading platforms accessible to Canadians may not have basic safeguards to protect investors’ assets from loss, theft or misuse.”
Quebec addresses CGIAnd the 5N moreAnd the subway And the Uni-Select It hit a 52-week high on the Toronto Stock Exchange this week. in contrast, GuruAnd the bmtcAnd the Hexa And the Bitfarms It reached its lowest level in 52 weeks.